Gene: MMP9
Official Full Name: matrix metallopeptidase 9provided by HGNC
Gene Summary: Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The enzyme encoded by this gene degrades type IV and V collagens. Studies in rhesus monkeys suggest that the enzyme is involved in IL-8-induced mobilization of hematopoietic progenitor cells from bone marrow, and murine studies suggest a role in tumor-associated tissue remodeling. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00153 | MMP9 Knockout cell line (HEK293) | Human | MMP9 | 1:3~1:6 | Negative | Online Inquiry |
MMP9 Gene Knockout Cell Lines are specifically engineered cellular models where the matrix metalloproteinase 9 (MMP9) gene has been inactivated or deleted. These cell lines serve as a powerful tool for researchers to investigate the biological role of MMP9 in various physiological and pathological processes, particularly those related to inflammation, tissue remodeling, and cancer metastasis. MMP9 is known for its ability to degrade extracellular matrix components, making it pivotal in extracellular matrix turnover and cell migration. The mechanisms by which these knockout lines operate include altered signaling pathways and changes in cellular behaviors, providing insights into the MMP9-mediated cellular responses.
The scientific importance of MMP9 Gene Knockout Cell Lines extends to various research fields, including cancer biology, immunology, and regenerative medicine. In clinical settings, understanding MMP9's involvement in disease mechanisms can lead to the identification of novel therapeutic targets and the development of innovative treatment strategies. By employing these knockout cell lines, researchers are poised to delineate the contributions of MMP9 in pathological conditions more effectively than traditional methods allow.
Compared to alternative models, such as wild-type or overexpressing systems, MMP9 Gene Knockout Cell Lines offer unique advantages, including the ability to observe the direct effects of MMP9 loss on cell behavior without confounding factors. This specificity enhances the reliability of experimental data and enables more precise interpretations of results.
For researchers and clinicians, these knockout cell lines provide an invaluable resource for mechanistic studies, drug discovery, and the validation of therapeutic interventions targeting MMP9. Ultimately, they streamline the research process and aid in advancing our understanding of complex biological phenomena.
Our company specializes in the development and provision of high-quality biological products tailored for cutting-edge research and clinical applications. With expertise in genomic tools and cellular biology, we are dedicated to supporting scientific innovation and helping advance the frontiers of biomedical research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.